Bought
Maintained
Sold
Other funds holding BXC
FS
SCM
PGCM
CC
NGA
HCS
AC
UBS's BXC Position: Q3 2014 in Review
UBS reduced its BlueLinx (BXC) stake by 94% in Q3 2014, selling an estimated $2.23K and leaving 12 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #10372.
UBS first reported a position in BXC in Q2 2013 and has held it in 5 quarters since. The position peaked at $8K in Q2 2013. 37 funds tracked by Wall St. Rank hold BXC as of Q3 2014.
- UBS held 12 shares of BlueLinx worth $0 as of Q3 2014.
- UBS sold 176 BlueLinx shares in Q3 2014, an estimated $2.23K.
- BlueLinx made up ﹤0.01% of UBS's portfolio in Q3 2014, its #10372 holding.
- UBS first reported a position in BlueLinx in Q2 2013 and has held it in 5 quarters since.
- UBS's BlueLinx position peaked at $8K in Q2 2013.
- 37 funds tracked by Wall St. Rank held BlueLinx as of Q3 2014.
Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.